Basic Information
Bio-Quant, a wholly-owned subsidiary of NexMed, is one of the most experienced contract research organizations in the San Diego area, specializing in in vitro and in vivo contract drug discovery and preclinical development services. Bio-Quant has grown by more than 250% over the past five years and continues to expand. Bio-Quant provides non-GLP drug discovery research services with expertise in oncology, inflammation, immunology, and diabetes.